Cytek Biosciences Inc.
Organization details
- Legal name
- Cytek Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 3826 — Laboratory Analytical Instruments
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Fremont
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CTKB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001831915
- EIN
- 47-2547526
Board of directors
-
Deborah J. Neff · DirectorSince 2023
-
Don M. Hardison · DirectorSince 2023
-
Gisele Dion · DirectorSince 2023
-
Glenn P. Muir · DirectorSince 2026
-
Jack Ball · DirectorSince 2023
-
Michael Holder · DirectorSince 2024
-
Ming Yan · Director · CHIEF TECHNOLOGY OFFICERSince 2023
-
Richard Chin · DirectorSince 2025
-
Vera Imper · DirectorSince 2023
-
Wenbin Jiang · Director · PRESIDENT AND CEOSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
75.8%
-
89.8%
-
93.1%
Board connections
4 of this board's directors also sit on 4 other boards.
- via Don M. Hardison and Michael Holder
- via Gisele Dion
- via Glenn P. Muir
- via Glenn P. Muir
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Richard Chin Director | Option exercise | +6,107 | — | — |
| Aug 18, 2026 | Glenn P. Muir Director | Option exercise | +3,086 | — | — |
| Aug 18, 2026 | Michael Holder Director | Option exercise | +2,181 | — | — |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Option exercise | +11,781 | — | — |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Option exercise | +7,363 | — | — |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Option exercise | +6,320 | — | — |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Shares withheld for tax | −2,869 | $4.67 | $13,398 |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Shares withheld for tax | −1,778 | $4.67 | $8,303 |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Shares withheld for tax | −2,111 | $4.67 | $9,858 |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Option exercise | +22,100 | — | — |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Option exercise | +5,525 | — | — |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Option exercise | +13,051 | — | — |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Shares withheld for tax | −5,382 | $4.67 | $25,134 |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Shares withheld for tax | −1,346 | $4.67 | $6,286 |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Shares withheld for tax | −4,392 | $4.67 | $20,511 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cytek Biosciences Inc.
Who is the CEO of Cytek Biosciences Inc.?
Wenbin Jiang is Cytek Biosciences Inc.'s President and CEO.
How many directors are on Cytek Biosciences Inc.'s board?
Cytek Biosciences Inc.'s board has 10 directors: Deborah J. Neff, Don M. Hardison, Gisele Dion, Glenn P. Muir, Jack Ball, Michael Holder, Ming Yan, Richard Chin, Vera Imper and Wenbin Jiang.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cytek-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.